Kyriazis Zisis, Kollia Panagoula, Grivea Ioanna, Varitimidis Sokratis E, Constantoulakis Pantelis, Dailiana Zoe H
Department of Orthopaedic Surgery, Medical School, University of Thessaly, Larissa, Greece.
Department of Genetics and Biotechnology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Eur J Orthop Surg Traumatol. 2019 Feb;29(2):421-426. doi: 10.1007/s00590-018-2343-3. Epub 2018 Nov 29.
Molecular analysis of different types of thumb duplication and identification of new suspected gene mutations.
In a series of patients operated for polydactyly, DNA was extracted from blood samples collected preoperatively. Among these, the samples of two patients with thumb duplication (Wassel types III and IV) were initially selected for molecular analysis. The method of Clinical Exome Solution was used for the study of the phenotype-involved genes. Next-generation sequencing (NGS) was performed on a NextSeq-500 Platform (Illumina), and Sophia DDM SaaS algorithms were used for the bioinformatics analysis of the data.
In total, 8-including 4 new-mutations were detected in CEP290 (1 mutation), RPGRIP1 (2 mutations), TMEM216 (2 mutations), FBN1 (1 mutation), CEP164 (1 mutation), and MEGF8 (1 mutation) genes. NGS revealed 3 mutated genes in the patient with Wassel III thumb duplication and 5 mutated genes in the patient with Wassel IV duplication. The molecular analysis revealed that the patients had 2 mutated genes in common, but they only shared one common mutation.
The new detected mutations are most probably associated with thumb duplication, as they belong to genes with already described mutations causing ciliopathies, often including polydactyly in their phenotype. Recognition of these mutations will be helpful to prenatal diagnosis, operative treatment strategy prediction, and possible future experimental applications in gene therapy.
对不同类型的拇指多指畸形进行分子分析,并鉴定新的疑似基因突变。
在一系列因多指畸形接受手术的患者中,从术前采集的血液样本中提取DNA。其中,最初选择了两名患有拇指多指畸形(瓦塞尔III型和IV型)患者的样本进行分子分析。采用临床外显子解决方案方法研究涉及表型的基因。在NextSeq-500平台(Illumina)上进行下一代测序(NGS),并使用Sophia DDM SaaS算法对数据进行生物信息学分析。
在CEP290(1个突变)、RPGRIP1(2个突变)、TMEM216(2个突变)、FBN1(1个突变)、CEP164(1个突变)和MEGF8(1个突变)基因中总共检测到8个突变,其中包括4个新突变。NGS显示,瓦塞尔III型拇指多指畸形患者中有3个突变基因,瓦塞尔IV型多指畸形患者中有5个突变基因。分子分析显示,这两名患者有2个共同的突变基因,但他们仅共享一个共同突变。
新检测到的突变很可能与拇指多指畸形相关,因为它们属于已描述的导致纤毛病的突变基因,其表型通常包括多指畸形。识别这些突变将有助于产前诊断、手术治疗策略预测以及未来可能的基因治疗实验应用。